The Clorox Company (NYSE:CLX) is ExodusPoint Capital Management LP’s 9th Largest Position

ExodusPoint Capital Management LP raised its holdings in The Clorox Company (NYSE:CLX) by 187.9% during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 698,900 shares of the company’s stock after acquiring an additional 456,114 shares during the period. Clorox makes up 0.8% of ExodusPoint Capital Management LP’s investment portfolio, making the stock its 9th largest position. ExodusPoint Capital Management LP owned about 0.56% of Clorox worth $113,508,000 as of its most recent SEC filing.

Other large investors have also recently modified their holdings of the company. Vanguard Group Inc. raised its stake in Clorox by 0.8% in the fourth quarter. Vanguard Group Inc. now owns 15,507,152 shares of the company’s stock valued at $2,518,517,000 after purchasing an additional 124,428 shares in the last quarter. State Street Corp raised its position in shares of Clorox by 3.1% during the 3rd quarter. State Street Corp now owns 8,182,109 shares of the company’s stock valued at $1,332,947,000 after buying an additional 245,525 shares in the last quarter. Geode Capital Management LLC lifted its holdings in shares of Clorox by 2.3% during the 4th quarter. Geode Capital Management LLC now owns 3,098,302 shares of the company’s stock worth $501,925,000 after acquiring an additional 69,969 shares during the last quarter. Stifel Financial Corp grew its position in Clorox by 1.7% in the third quarter. Stifel Financial Corp now owns 2,334,826 shares of the company’s stock worth $380,370,000 after acquiring an additional 37,967 shares in the last quarter. Finally, Norges Bank bought a new position in Clorox in the fourth quarter valued at $259,041,000. Institutional investors own 78.53% of the company’s stock.

Clorox Trading Down 0.1 %

CLX opened at $147.77 on Thursday. The Clorox Company has a one year low of $127.60 and a one year high of $171.37. The company has a debt-to-equity ratio of 20.52, a current ratio of 0.94 and a quick ratio of 0.60. The business has a 50 day simple moving average of $150.61 and a two-hundred day simple moving average of $158.66. The firm has a market capitalization of $18.20 billion, a price-to-earnings ratio of 40.37, a PEG ratio of 2.62 and a beta of 0.45.

Clorox (NYSE:CLX) last announced its earnings results on Monday, February 3rd. The company reported $1.55 EPS for the quarter, beating analysts’ consensus estimates of $1.39 by $0.16. Clorox had a return on equity of 316.87% and a net margin of 6.38%. During the same quarter in the prior year, the firm earned $2.16 earnings per share. Analysts predict that The Clorox Company will post 7.15 EPS for the current year.

Clorox Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, May 9th. Investors of record on Wednesday, April 23rd will be given a dividend of $1.22 per share. The ex-dividend date is Wednesday, April 23rd. This represents a $4.88 annualized dividend and a dividend yield of 3.30%. Clorox’s dividend payout ratio is presently 133.33%.

Analyst Upgrades and Downgrades

A number of equities analysts recently weighed in on CLX shares. Barclays decreased their price objective on Clorox from $140.00 to $139.00 and set an “underweight” rating on the stock in a report on Thursday, March 27th. Evercore ISI lifted their price target on shares of Clorox from $145.00 to $155.00 in a research note on Tuesday, February 4th. DA Davidson cut their price objective on shares of Clorox from $171.00 to $169.00 and set a “neutral” rating for the company in a research note on Wednesday, February 5th. Wells Fargo & Company reduced their target price on shares of Clorox from $161.00 to $155.00 and set an “equal weight” rating on the stock in a report on Wednesday. Finally, JPMorgan Chase & Co. upped their price target on shares of Clorox from $171.00 to $173.00 and gave the company a “neutral” rating in a research report on Tuesday, February 4th. Three analysts have rated the stock with a sell rating, ten have issued a hold rating and one has issued a buy rating to the stock. According to data from MarketBeat, the stock has a consensus rating of “Hold” and an average price target of $159.00.

Clorox Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.